Searched for
AMGEN
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- MF Tracker: After a strong 7 year run, can this international fund maintain momentum?Motilal Oswal Nasdaq 100 FOF has delivered exceptional returns, outperforming equity mutual funds over seven years, driven by US tech giant...
- OpenAI launches AI model GPT-Rosalind for life sciences researchThe GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug ...
- US Stocks: Viridian shares plunge 34% as eye disease drug disappoints on efficacy despite trial successViridian Therapeutics shares slumped 34% to an eight-month low on Monday after its experimental treatment for thyroid eye disease lagged ri...
- Amgen to invest $200 million in India site, CEO saysAmgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre,...
- Amgen expands global capability centre in Hyderabad with 500,000 sq ft leaseAmgen leases 500,000 sq ft in Hyderabad to establish its first global capability centre, enhancing its office space in the city. The new ce...
- Biotech giant Amgen plans to open to technology & innovation centre in HyderabadUS biotech giant Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site will be located in HITEC ...
- The margin of safety: the ten-billion-dollar lesson from AmgenA notable book that emphasized the importance of corporate culture by looking at successful companies (stock price performance as a guide) ...
- Cipla settles case with Amgen Inc involving generic cinacalcet hydrochloride tabletsA formal stipulation of dismissal has been filed with the court and is awaiting signature by the presiding Judge, the filing added.
- Biocon puts arthritis drug on backburnerBiocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel.
- Company on a path of recovery; Q1 has been solid: Manoj Nerurkar, Syngene InternationalThey have established players in drug discovery, development and manufacturing, especially in the biologics areas, the large molecule area.
- Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...
- Dr Reddy's Lab shares up almost 2% on boursesShares of Dr Reddy's Laboratories rose almost 2% after the company said it has inked a pact with US-based biotechnology firm Amgen to marke...
- Dr Reddy's to market three Amgen drugs in IndiaDr Reddy's Laboratories today said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs.
- Amgen to purchase Micromet for $1.16 bn for Leukemia drugAmgen, the world's largest biotechnology company, agreed to buy Micromet in a $1.16 billion deal to gain an experimental leukemia drug.
- Cipla to partner Chinese co in selling Roche, Amgen drug clonesCipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...
- DRL to launch biosimilar drugs in Europe by '10India's largest drug maker, Dr Reddy’s Laboratories, is planning to introduce its first biosimilar drug by 2010 in Europe, a senior company...
- Global pharma cos explore contract research in IndiaA new chapter is being added to the Indian pharma story. Leading global pharma and biotechnology firms, such as Schering-Plough, Bristol-My...
Load More
